---
title: "Cindrella Financial Services Ltd (531283) — Share Price, Financials & Analysis"
symbol: "531283"
company: "Cindrella Financial Services Ltd"
canonical: "https://tapetide.com/stocks/531283"
isin: "INE897D01015"
nse_symbol: "CINDRELLAFINANCIALSERVICESLTD"
bse_code: "531283"
sector: "Financial Services"
industry: "NBFC"
market_cap_cr: 4.2
generated_at: "2026-09-13T18:59:05.615Z"
---

# Cindrella Financial Services Ltd (531283)

Canonical page: https://tapetide.com/stocks/531283

## Company

- **NSE Symbol:** CINDRELLAFINANCIALSERVICESLTD
- **BSE Code:** 531283
- **ISIN:** INE897D01015
- **Sector:** Financial Services
- **Industry:** NBFC
- **Macro Sector:** Financial Services
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** cindrellahotelsltd.com

## About

Incorporated in 1994, Cindrella Financial Services Ltd is in the business of providing loans and other finance services[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:38:53.753300Z.

- **Market Cap:** ₹4.2 Cr
- **Classification:** Microcap
- **P/E (reported):** 35.6
- **EPS (TTM):** ₹0.29
- **EPS (reported):** ₹0.55
- **Book Value:** ₹17.6
- **Price to Book:** 0.57
- **Dividend Yield:** 0%
- **ROE:** 1.97%
- **ROCE:** 2.52%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹0.2 Cr
- **Net Income:** ₹0.02 Cr
- **EBITDA:** ₹0.05 Cr
- **52-Week High:** ₹15.06
- **52-Week Low:** ₹8.6
- **RSI (14):** 8.73

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 0.64 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 10.8% over past five years.
- Promoter holding is low: 30.2%
- Company has a low return on equity of 3.26% over last 3 years.
- Working capital days have increased from 3,375 days to 10,147 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 12.5% | 22.22% | -625% |
| ebitda margin growth | 100% | -47.75% | -61.14% | -55.16% |
| net income growth | 100% | -80% | -63% | 19% |
| revenue growth | 0% | -33.33% | -43% | 11% |
| roce | -66.67% | -30.19% | -83.37% | 5.04% |
| roe | -140% | -18.26% | 5.7% | 185.51% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Revenue | 0.01 | 0.13 | 0.04 | 0.05 | 0.04 | 0.15 | 0.03 | -0.03 | 0.03 | 0.17 | 0.02 | 0.01 |
| Expenses | 0.02 | 0.01 | 0.03 | 0.02 | 0.04 | 0.03 | 0.05 | 0.03 | 0.03 | 0.03 | 0.06 | 0.04 |
| Financing Profit | -0.01 | 0.12 | 0.01 | 0.03 | 0 | 0.12 | -0.02 | -0.06 | 0 | 0.14 | -0.04 | -0.03 |
| Financing Margin % | -100 | 92.31 | 25 | 60 | 0 | 80 | -66.67 | 200 | 0 | 82.35 | -200 | -300 |
| Other Income | 0.03 | 0.01 | 0.08 | 0.02 | 0.02 | 0.01 | -0.01 | 0 | 0 | 0 | -0.02 | 0.01 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.02 | 0.13 | 0.09 | 0.05 | 0.02 | 0.13 | -0.03 | -0.06 | 0 | 0.14 | -0.06 | -0.02 |
| Tax % | 50 | 46.15 | 11.11 | 20 | 0 | 23.08 | -33.33 | 0 | — | 14.29 | -16.67 | 0 |
| Net Profit | 0.04 | 0.06 | 0.06 | 0.08 | 0.01 | 0.1 | 0.01 | -0.03 | 0.01 | 0.14 | -0.06 | 0.03 |
| EPS in Rs | 0.1 | 0.14 | 0.14 | 0.19 | 0.02 | 0.24 | 0.02 | -0.07 | 0.02 | 0.34 | -0.14 | 0.07 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Revenue | 0.04 | 0.08 | 0.11 | 0.12 | 0.23 | 1.08 | 0.33 | 0.32 | 0.2 | 0.23 |
| Expenses | 0.07 | 0.07 | 0.09 | 0.08 | 0.09 | 0.15 | 0.09 | 0.15 | 0.15 | 0.16 |
| Financing Profit | -0.03 | 0.01 | 0.02 | 0.04 | 0.14 | 0.93 | 0.24 | 0.17 | 0.05 | 0.07 |
| Financing Margin % | -75 | 12.5 | 18.18 | 33.33 | 60.87 | 86.11 | 72.73 | 53.12 | 25 | 30.43 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.02 | -0.01 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.03 | 0.01 | 0.02 | 0.04 | 0.14 | 0.93 | 0.24 | 0.17 | 0.03 | 0.06 |
| Tax % | 0 | 0 | 0 | 25 | 21.43 | 17.2 | 33.33 | 23.53 | 33.33 | — |
| Net Profit | 0.05 | 0.11 | 0.49 | -0.22 | 0.23 | 1.57 | 0.36 | 0.19 | 0.08 | 0.12 |
| EPS in Rs | 0.12 | 0.26 | 1.18 | -0.53 | 0.55 | 3.77 | 0.87 | 0.46 | 0.19 | 0.29 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 |
| Reserves | 0.58 | 0.62 | 0.74 | 1.09 | 0.87 | 1.22 | 2.77 | 3.17 | 3.28 | 3.16 |
| Borrowing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.17 | 0.13 | 0.13 | 0.11 | 0.12 | 0.21 | 0.14 | 0.14 | 0.09 | 0.06 |
| Total Liabilities | 4.05 | 4.05 | 4.17 | 4.5 | 4.29 | 4.73 | 6.21 | 6.61 | 6.67 | 6.52 |
| Fixed Assets | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 3.76 | 3.93 | 3.82 | 3.84 | 3.6 | 4.08 | 6.19 | 5.21 | 5.44 | 0 |
| Other Assets | 0.24 | 0.08 | 0.31 | 0.62 | 0.65 | 0.65 | 0.02 | 1.4 | 1.23 | 6.52 |
| Total Assets | 4.05 | 4.05 | 4.17 | 4.5 | 4.29 | 4.73 | 6.21 | 6.61 | 6.67 | 6.52 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.03 | -0.09 | -0.01 | 0 | 0.04 | 0 | -0.27 | -0.24 | -0.21 | -0.15 |
| Cash from Investing Activity | -0.03 | -0.11 | -0.01 | 0.01 | -0.04 | 0.36 | -0.06 | 0.16 | 0.35 | 0.78 |
| Cash from Financing Activity | 0 | 0 | 0 | 0 | 0 | -0.01 | -0.01 | 0.05 | 0.16 | 0 |
| Net Cash Flow | -0.06 | -0.2 | -0.02 | 0.01 | -0.01 | 0.35 | -0.34 | -0.03 | 0.3 | 0.63 |
| Free Cash Flow | 0.24 | -0.09 | -0.01 | 0 | 0.04 | 0 | -0.27 | -0.24 | -0.21 | -0.15 |
| CFO/OP | -100 | 300 | -100 | 50 | 125 | 7 | -13 | -38 | -82 | -280 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ROE % | 1.1 | 1.28 | 2.76 | 11.63 | -5.14 | 5.29 | 29.65 | 5.74 | 2.91 | 1.23 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 30.21% | 30.21% | 30.21% | 30.21% | 30.21% | 30.21% | 30.21% | 30.21% | 30.21% | 30.21% | 30.21% | 30.21% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 37.34% | 37.16% | 37.16% | 37.16% | 37.16% | 37.48% | 37.54% | 37.58% | 37.79% | 38.07% | 38.07% | 38.06% |
| Others | 32.44% | 32.62% | 32.63% | 32.63% | 32.63% | 32.31% | 32.25% | 32.21% | 32% | 31.72% | 31.72% | 31.73% |
| No. of Shareholders | 2790 | 2885 | 2847 | 2810 | 2824 | 2901 | 2901 | 2919 | 2914 | 2899 | 2878 | 2860 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 4 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 10.24 | Sell |
| EMA (10) | 10.31 | Sell |
| SMA (20) | 10.83 | Sell |
| EMA (20) | 10.47 | Sell |
| SMA (50) | 10.14 | Sell |
| EMA (50) | 10.39 | Sell |
| SMA (100) | 10.37 | Sell |
| EMA (100) | 10.62 | Sell |
| SMA (200) | 11.76 | Sell |
| EMA (200) | 11.3 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 41.07 | Neutral |
| MACD (12,26,9) | -0.1 | Sell |
| Stochastic (14,3,3) | 11.46 | Buy |
| ADX (14) | 20.99 | Neutral |
| Williams %R (14) | -100 | Buy |
| ATR (14) | 0.21 | Neutral |
| ROC (12) | -13.22 | Sell |
| Stoch RSI (14) | 11.74 | Buy |
| UO (7,14,28) | 31.71 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-05 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e07a696-549a-4038-ad62-08ea27f56044.pdf) |
| 2026-08-27 | [Corporate Action- Fixed Book Closure For Holding Of AGM On 29-9-2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef3bb31a-0c24-4e93-a002-bc233dabf6ea.pdf) |
| 2026-08-27 | [Shareholders Meeting/AGM On 29-9-2026 At 4.30 Pm](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3bcae84-db1a-4ac6-b598-39983c2ad11d.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI(LODR) Regulations 2015 For The QE June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43fa8bd0-986e-4276-b178-176e9e9fbaaf.pdf) |
| 2026-08-08 | [Board Meeting Intimation for Intimation Of Board Meeting Intimation To Be Held On 14Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04533d5b-6a7b-45bb-8184-cc5d50a118c2.pdf) |
| 2026-07-14 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45202b81-e1d2-4f3a-8a15-b7330a6d4563.pdf) |
| 2026-05-30 | [Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI(LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42c63fa1-0edb-4d0b-89ae-4b5270625b8c.pdf) |
| 2026-05-28 | [Compliances-Reg.24(A)-Annual Secretarial Compliance](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f21e0f92-d621-4563-bb74-138615f629ba.pdf) |
| 2026-05-15 | [Board Meeting Intimation for Board Meeting Intimation For Results & Closure Of Trading Window Under Regulation 29 Of SEBI(LODR) Regulations 2015 Ref: Cindrella Financial Services Ltd Script Code 531283](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7fa9b4a-4c65-4061-add6-b4b295ceec54.pdf) |
| 2026-05-15 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e99f95a-0b42-48e6-bce2-97ba5eb3e665.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Results - Financial Results For The QE June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a2e6ae7-a8b5-428e-9889-d6e4047210b6.pdf) |
| 2026-05-30 | [Financial Results For The Quarter And Year Ended 31/03/2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=057222cc-0e06-4146-b5a5-c86930201997.pdf) |
| 2026-02-13 | [Standalone And Consolidated Financial Results For The Quarter Ended December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3fd71f8-7e59-47ae-8a0d-d3ba2e7bc1f8.pdf) |
| 2025-11-10 | [Financial Result For The Quarter Ended September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2f8e128-c829-4a04-8fef-5c1fe0bce27d.pdf) |
| 2025-08-13 | [FINANCIAL RESULT FOR THE QE JUNE 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29251020-149b-4f45-8660-fdbe100dd589.pdf) |
| 2025-05-30 | [FINANCIAL RESULT FOR THE QUARTER AND YEAR ENDED 31/03/2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98f8b394-1d26-49c5-a5dd-91b44dc1bf9e.pdf) |
| 2025-02-14 | [Result For The QE December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc7bceb0-4b02-4d10-9e8a-024036fa82c8.pdf) |
| 2024-11-14 | [UNAUDITED FINANCIAL RESULT FOR THE QE SEPTEMBER, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5b35e9f-011a-4e2a-9c83-3cc1ed5eb923.pdf) |
| 2024-10-23 | [REVISED FINANCIAL RESULT FOR THE QE JUNE 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2561e112-ce6e-452e-a213-bd601882b566.pdf) |
| 2024-10-02 | [Result For The QE June, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd112228-642c-407f-b2d0-8745c90cfa92.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Of Schedule of Investors/Analysts meetings Under SEBI (LODR) Regulations, 2015 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 9 Feb - Of Schedule of Investors/Analysts meetings Under SEBI (LODR) Regulations, 2015](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3030ccff-662c-415b-b1bb-e92740edf092.pdf) |
| 6 Feb - Board meeting 13 Feb 2026 to approve unaudited results for period ended 31/12/2025. | [Board Meeting Intimation for Intimation Of Board Meeting Intimation To Be Held On 13Th February, 2026 6 Feb - Board meeting 13 Feb 2026 to approve unaudited results for period ended 31/12/2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ef522dc8-4fb3-4294-bea5-e60d6087992f.pdf) |
| 4 Feb - Transcript of earnings conference call on financial results for the quarter ended December 31, 2025. | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 4 Feb - Transcript of earnings conference call on financial results for the quarter ended December 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/931c0806-b248-4d46-8968-3e4662d841ba.pdf) |
| 30 Jan - Audio recording of Indegene Q3FY26 earnings call, held 30 Jan 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 30 Jan - Audio recording of Indegene Q3FY26 earnings call, held 30 Jan 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e8d06526-dea5-48e7-87da-a8c193e8f7c8.pdf) |
| 25 Feb - Investor meetings Mar 2 (Locus, virtual) and Mar 5 (Buoyant, in-person, Bengaluru). | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 25 Feb - Investor meetings Mar 2 (Locus, virtual) and Mar 5 (Buoyant, in-person, Bengaluru).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7259a875-5f5b-4c9b-bfec-f2c122661921.pdf) |
| 16 Feb - Investor/analyst 1x1 meetings scheduled 19–25 Feb 2026 with mutual funds and conferences in Bangalore/Mumbai. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 16 Feb - Investor/analyst 1x1 meetings scheduled 19–25 Feb 2026 with mutual funds and conferences in Bangalore/Mumbai.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8b3d6fc1-4d4d-4536-8271-48f5ea4b9324.pdf) |
| 15 Jan - Dear Sir, We are submitting the Certificate Under Regulation 74 (5) of the SEBI (DP) Regulations, 2019 for the QE Dec, 2025 in the attachment. … | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 15 Jan - Dear Sir, We are submitting the Certificate Under Regulation 74 (5) of the SEBI (DP) Regulations, 2019 for the QE Dec, 2025 in the attachment. …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9c118182-6ab1-4eea-bc6c-486082998828.pdf) |
| 14 Apr - Dear Sir/Madam Please find herewith the Certificate Under Regulation 74 (5) of the SEBI (Depositories Participants) Regulations, 2019 for the QE March, 2026 in the … | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Apr - Dear Sir/Madam Please find herewith the Certificate Under Regulation 74 (5) of the SEBI (Depositories Participants) Regulations, 2019 for the QE March, 2026 in the …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3a219842-b4bc-4b9e-8019-020e80025427.pdf) |
| 13 Feb - Board approved unaudited standalone and consolidated results for quarter ended December 2025; meeting on 13-Feb-2026. | [Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI(LODR) Regulations, 2015 13 Feb - Board approved unaudited standalone and consolidated results for quarter ended December 2025; meeting on 13-Feb-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/56f80a97-886d-4b0a-b7c0-8eae55578f67.pdf) |
| 1 Mar - Indegene Healthcare UK to acquire DT UK (£2,001,000) and Trilogy UK (£702,348); completion by 31-Mar-2026. | [Announcement under Regulation 30 (LODR)-Acquisition 1 Mar - Indegene Healthcare UK to acquire DT UK (£2,001,000) and Trilogy UK (£702,348); completion by 31-Mar-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d5383f44-c155-488a-9266-d769c0e50daa.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e16c1f8b-450a-4754-a0ec-9645850e201c.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7bcf4678-8fb3-4c19-9104-aa93e94117b6.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/764ca348-f737-4e69-9e5d-7915743aa0a8.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/505402ff-db3e-4871-a707-0dd27d861577.pdf) |
| Mar 2025 | [Concall - Mar 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8bb93608-73fb-4e39-b38c-f42bb5d7ec15.pdf) |
| Jun 2024 | [Concall - Jun 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d305f3fe-bb01-4c6e-bc50-5dc183822aa7.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/91b65492-ffc7-4c6e-9b15-1e14c633bbb6.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4cb147b1-85e6-4b4d-975d-5b557c8b7f46.pdf) |
| Aug 2024 | [Concall - Aug 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/73eae4c5-07cd-4be2-802b-3e4e040d87b4.pdf) |
| Aug 2024 | [Concall - Aug 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e4d47668-62c0-47db-9a6e-4207a46fa7fd.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/04cd4545-e397-49d0-a4e6-491582728dbb.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4b9f3391-f6d1-47f5-bda2-7a5817ce5540.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e1461432-d0da-4938-84cc-03582464e914.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/03753231-838a-4311-a862-574dca3e137d.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6ba296a5-3bca-4777-ae34-0dff3f50245c.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/531283/74767531283.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/531283/72555531283.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/531283/67257531283.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/531283/5312830319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/531283/5312830318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:59:05.615Z.